HLA-Mismatched Unrelated Donor Bone Marrow Transplantation With Post-Transplantation Cyclophosphamide

Clinical trial NCT02793544 · COMPLETED

Trial details

NCT number: NCT02793544
Sponsor: Center for International Blood and Marrow Transplant Research
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Myelodysplastic Syndrome (MDS)Chronic Lymphocytic Leukemia (CLL)Chemotherapy-sensitive Lymphoma Acute Lymphoblastic Leukemia (ALL)/T Lymphoblastic Lymphoma Acute Myelogenous Leukemia (AML)Acute Biphenotypic Leukemia (ABL)Acute Undifferentiated Leukemia (AUL)

Start date: 2016-12-01
Primary completion: 2020-03-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.